| # | Drug | Count |
|---|---|---|
| 0 | CITALOPRAM | 3 |
| 1 | GALCANEZUMAB-GNLM | 3 |
| 2 | TOPIRAMATE | 3 |
| 3 | ACETAMINOPHEN | 2 |
| 4 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 5 | ADALIMUMAB | 2 |
| 6 | BUPROPION HYDROCHLORIDE | 2 |
| 7 | CITALOPRAM HYDROBROMIDE | 2 |
| 8 | GABAPENTIN | 2 |
| 9 | GLECAPREVIR AND PIBRENTASVIR | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 1 | IBANDRONATE SODIUM | 1 | 0.0003 |
| 2 | ELBASVIR AND GRAZOPREVIR | 1 | 0.0002 |
| 3 | GLECAPREVIR AND PIBRENTASVIR | 2 | 0.0002 |
| 4 | ROFLUMILAST | 1 | 0.0001 |
| 5 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | EPTINEZUMAB-JJMR | 1 | 0.0001 |
| 7 | GALCANEZUMAB-GNLM | 3 | 0.0001 |
| 8 | BUSPIRONE HYDROCHLORIDE | 1 | 0.0001 |
| 9 | CLOTRIMAZOLE TOPICAL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 3 | 0.0002 |
| 2 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 3 | Progesterone [EPC] | 2 | 0.0001 |
| 4 | Hepatitis C Virus NS5A Inhibitor [EPC] | 4 | 0.0001 |
| 5 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 2 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Androgen [EPC] | 1 | 0.0000 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |